Brainstorm Cell Therapeutics Inc. (BCLI)
NASDAQ: BCLI · Real-Time Price · USD
2.280
+0.200 (9.62%)
At close: Dec 20, 2024, 4:00 PM
2.290
+0.010 (0.44%)
After-hours: Dec 20, 2024, 5:11 PM EST
BCLI Analyst Ratings
Total Analysts
1
Consensus Rating
Strong Buy
Price Target
$30.00
Upside
+1,215.79%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Hold → Strong Buy Upgrades $30 | Hold → Strong Buy | Upgrades | $30 | +1,215.79% | Jul 11, 2024 |
| Maxim Group | Maxim Group | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Sep 28, 2023 |
| Maxim Group | Maxim Group | Strong Buy Maintains $75 → $150 | Strong Buy | Maintains | $75 → $150 | +6,478.95% | Mar 31, 2023 |
| Maxim Group | Maxim Group | Hold → Strong Buy Upgrades n/a | Hold → Strong Buy | Upgrades | n/a | n/a | Feb 5, 2021 |
| Maxim Group | Maxim Group | Strong Buy Maintains $120 → $135 | Strong Buy | Maintains | $120 → $135 | +5,821.05% | Aug 17, 2017 |